UNLABELLED: High photon attenuation and scatter in obese patients affect image quality. The purpose of the current study was to optimize lutetium orthosilicate (LSO) PET image acquisition protocols in patients weighing > or =91 kg (200 lb). METHODS: Twenty-five consecutive patients (16 male and 9 female) weighing > or =91 kg (200 lb; range, 91-168 kg [200-370 lb]) were studied with LSO PET/CT. After intravenous injection of 7.77 MBq (0.21 mCi) of 18F-FDG per kilogram of body weight, PET emission scans were acquired for 7 min/bed position. Single-minute frames were extracted from the 7 min/bed position scans to reconstruct 1-7 min/bed position scans for each patient. Three reviewers independently analyzed all 7 reconstructed whole-body images of each patient. A consensus reading followed in cases of disagreement. Thus, 175 whole-body scans (7 per patient) were analyzed for number of hypermetabolic lesions. A region-of-interest approach was used to obtain a quantitative estimate of image quality. RESULTS: Fifty-nine hypermetabolic lesions identified on 7 min/bed position scans served as the reference standard. Interobserver concordance increased from 64% for 1 min/bed position scans to 70% for 3 min/bed position scans and 78% for 4 min/bed position scans. Concordance rates did not change for longer imaging durations. Region-of-interest analysis revealed that image noise decreased from 21% for 1 min/bed position scans to 14%, 13%, and 11% for, respectively, 4, 5, and 7 min/bed position scans. When compared with the reference standard, 14 lesions (24%) were missed on 1 min/bed position scans but only 2 (3%) on 4 min/bed position scans. Five minute/bed position scans were sufficient to detect all lesions identified on the 7 min/bed position scans. CONCLUSION: Lesion detectability and reader concordance peaked for 5 min/bed position scans, with no further diagnostic gain achieved by lengthening the duration of PET emission scanning. Thus, 5 min/bed position scans are sufficient for optimal lesion detection with LSO PET/CT in obese patients.
UNLABELLED: High photon attenuation and scatter in obesepatients affect image quality. The purpose of the current study was to optimize lutetium orthosilicate (LSO) PET image acquisition protocols in patients weighing > or =91 kg (200 lb). METHODS: Twenty-five consecutive patients (16 male and 9 female) weighing > or =91 kg (200 lb; range, 91-168 kg [200-370 lb]) were studied with LSO PET/CT. After intravenous injection of 7.77 MBq (0.21 mCi) of 18F-FDG per kilogram of body weight, PET emission scans were acquired for 7 min/bed position. Single-minute frames were extracted from the 7 min/bed position scans to reconstruct 1-7 min/bed position scans for each patient. Three reviewers independently analyzed all 7 reconstructed whole-body images of each patient. A consensus reading followed in cases of disagreement. Thus, 175 whole-body scans (7 per patient) were analyzed for number of hypermetabolic lesions. A region-of-interest approach was used to obtain a quantitative estimate of image quality. RESULTS: Fifty-nine hypermetabolic lesions identified on 7 min/bed position scans served as the reference standard. Interobserver concordance increased from 64% for 1 min/bed position scans to 70% for 3 min/bed position scans and 78% for 4 min/bed position scans. Concordance rates did not change for longer imaging durations. Region-of-interest analysis revealed that image noise decreased from 21% for 1 min/bed position scans to 14%, 13%, and 11% for, respectively, 4, 5, and 7 min/bed position scans. When compared with the reference standard, 14 lesions (24%) were missed on 1 min/bed position scans but only 2 (3%) on 4 min/bed position scans. Five minute/bed position scans were sufficient to detect all lesions identified on the 7 min/bed position scans. CONCLUSION: Lesion detectability and reader concordance peaked for 5 min/bed position scans, with no further diagnostic gain achieved by lengthening the duration of PET emission scanning. Thus, 5 min/bed position scans are sufficient for optimal lesion detection with LSO PET/CT in obesepatients.
Authors: David Izquierdo-Garcia; Stephen J Sawiak; Karin Knesaurek; Jagat Narula; Valentin Fuster; Joseph Machac; Zahi A Fayad Journal: Eur J Nucl Med Mol Imaging Date: 2014-03-21 Impact factor: 9.236
Authors: Solange A Nogueira; Renato Dimenstein; Marcelo L Cunha; Jairo Wagner; Marcelo B G Funari; Henrique M Lederman Journal: Radiol Med Date: 2014-06-06 Impact factor: 3.469
Authors: Matthias R Benz; Ken Herrmann; Franziska Walter; Edward B Garon; Karen L Reckamp; Robert Figlin; Michael E Phelps; Wolfgang A Weber; Johannes Czernin; Martin S Allen-Auerbach Journal: J Nucl Med Date: 2011-11 Impact factor: 10.057
Authors: Matthias R Benz; Johannes Czernin; William D Tap; Jeffrey J Eckardt; Leanne L Seeger; Martin S Allen-Auerbach; Sarah M Dry; Michael E Phelps; Wolfgang A Weber; Fritz C Eilber Journal: Sarcoma Date: 2010-04-18
Authors: Matthias R Benz; Johannes Czernin; Martin S Allen-Auerbach; William D Tap; Sarah M Dry; David Elashoff; Kira Chow; Vladimir Evilevitch; Jeff J Eckardt; Michael E Phelps; Wolfgang A Weber; Fritz C Eilber Journal: Clin Cancer Res Date: 2009-04-07 Impact factor: 12.531
Authors: Matthias R Benz; Johannes Czernin; Sarah M Dry; William D Tap; Martin S Allen-Auerbach; David Elashoff; Michael E Phelps; Wolfgang A Weber; Fritz C Eilber Journal: Cancer Date: 2010-01-15 Impact factor: 6.860
Authors: Matthias R Benz; Martin S Allen-Auerbach; Fritz C Eilber; Hui J J Chen; Sarah Dry; Michael E Phelps; Johannes Czernin; Wolfgang A Weber Journal: J Nucl Med Date: 2008-09-15 Impact factor: 10.057